Araştırma Makalesi

Evaluation of spontaneous gingival bleeding and related drug withdrawal frequency in atrial fibrillation patients using oral anticoagulants: a case-controlled study

Cilt: 46 Sayı: 1 31 Mart 2021
PDF İndir
TR EN

Evaluation of spontaneous gingival bleeding and related drug withdrawal frequency in atrial fibrillation patients using oral anticoagulants: a case-controlled study

Abstract

Purpose: The aim of this study was to investigate the frequency of gingival bleeding (GB) and associated drug-withdrawal in atrial fibrillation (AF) patients using oral anti-coagulants (OAC). Materials and Methods: 457 patients with AF receiving OAC were screened. The periodontal parameters and OAC drug-withdrawal of 32 patients with spontaneous GB were compared with 32 patients without bleeding who were matched for age, sex and OAC treatment protocol. Results: GB was detected in 32 patients (7.0%) and 13 of these patients (40.6%) had OAC drug-withdrawal due to bleeding. The plaque index (PI), gingival index (GI) and probing pocket depths (PPD) were significantly higher in patients with GB. The GI scores independently determined the risk of OAC drug-withdrawal. Conclusion: AF patients under OAC treatment may have significant rates of GB and subsequent OAC withdrawal due to pre-existing periodontal disease. The GI scores and GB can predict the risk of OAC drug-withdrawal. The periodontal examination and/or treatment of these patients should be performed before OAC treatment.

Keywords

Atrial fibrillation , oral anti-coagulant therapy , periodontal disease , gingival bleeding

Kaynakça

  1. Muhlemann H: Gingival sulcus bleeding-a leading symptom in initial gingivitis. Helv Odontol Acta. 1971;15:107-13.
  2. Weinberg MA, Hassan H: Bleeding on probing: what does it mean? Gen Dent. 2012;60:271-6
  3. Bondon‐Guitton E, Mourgues T, Rousseau V, Cousty S, Cottin J, Drablier G, Micallef J, Montastruc JL: Gingival bleeding, a possible “serious” adverse drug reaction: An observational study in the French PharmacoVigilance Database. J Clin Periodontol. 2017;44:898-904.
  4. Tack DA, Rogers III RS: Oral drug reactions. Dermatol Ther. 2002;15:236-50.
  5. Little JW, Little JW. Dental management of the medically compromised patient. Elsevier Mosby, 2008.
  6. Aster RH, Curtis BR, McFarland JG, Bougie DW: Drug‐induced immune thrombocytopenia: pathogenesis, diagnosis, and management. J Thromb Haemost. 2009;7:911-18.
  7. Hughes M, Lip G: Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review. QJM: Int J Med. 2007;100:599-607.
  8. Wyndham CR. Atrial fibrillation: the most common arrhythmia. Tex Heart Inst J. 2000;27:257-267.
  9. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener H-C, Heidbuchel H, Hendriks JJEjoc-ts: 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2016;50(5):e1-e88.
  10. Wu L, Chang Q, Wang T, Zhang Z, Lou Y. Clinical observation of postoperative warfarin anticoagulation in 300 patients undergoing mitral valve replacement with a carbomedics mechanical valve. Heart Surg Forum. 2015;18:E063-E066.

Kaynak Göster

MLA
Özcan, Mustafa, ve Hasan Koca. “Evaluation of spontaneous gingival bleeding and related drug withdrawal frequency in atrial fibrillation patients using oral anticoagulants: a case-controlled study”. Cukurova Medical Journal, c. 46, sy 1, Mart 2021, ss. 325-31, doi:10.17826/cumj.803059.